Disease/Infection News

RSS

Scientists find that human embryos are vulnerable to COVID

A University of California, Riverside study reports that cells in the earliest stages of human development could be susceptible to infection by SARS-CoV-2, which causes COVID-19, offering new insight into how the virus interacts with developing human tissues and why that may matter for pregnancy research.

4 May 2026

New tools for quicker and easier Mpox diagnosis

Following the rise in monkeypox (Mpox) cases, particularly in countries where the disease had not traditionally been observed, the World Health Organization (WHO) declared a Public Health Emergency of International Concern in June 2022 and again in August 2024.

4 May 2026

New genetic risk report reveals hidden heart disease risk before symptoms appear

Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using large U.S.-based biobank data. The clinically orderable report may help identify inherited cardiovascular risk that traditional clinical markers can miss, although broader prospective validation is still needed.

30 Apr 2026

U.S. fails key measles elimination indicators amid rising outbreaks

After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Center for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track.

30 Apr 2026

Portable MiniDock MTB delivers tuberculosis results in thirty minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer.

30 Apr 2026

HPV infections continue after age 27, so who is still at risk?

HPV infections in women aged 27+ highlight the need for updated vaccination policies, emphasizing ongoing risk and the importance of preventive healthcare.

30 Apr 2026

WHO validates Australia for eliminating trachoma as public health problem

The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of Indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs).

29 Apr 2026

Extreme weather and airborne dust linked to rising Valley fever cases in El Paso

A new study by researchers at The University of Texas at El Paso has identified a significant rise in Valley fever cases in El Paso over the past decade and found strong connections between the disease and extreme weather, wind and airborne dust.

29 Apr 2026

New vaccine strategy neutralizes diverse HIV variants

Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralising highly divergent HIV variants.

29 Apr 2026

How media choices shape MMR vaccine hesitancy in the US

The study examines how media sources impact MMR vaccine attitudes, revealing a connection between non-mainstream outlets and increased vaccine hesitancy.

29 Apr 2026

Why H2N2 flu is back on the pandemic preparedness radar

A historical review in Vaccine warns that global H2N2 immunity has sharply declined since the 1957 Asian influenza pandemic, leaving most people without H2-specific protection if the virus re-emerges. The authors highlight animal reservoirs, waning birth-cohort immunity, and modern H2 vaccine platforms as key priorities for pandemic preparedness.

28 Apr 2026

Hepatitis C infection associated with reduced portal insulin levels

Insulin resistance is a common extrahepatic manifestation of hepatitis C virus (HCV) infection (HCVi), but its mechanism is poorly understood.

28 Apr 2026

New AI models quickly find compounds that target Lyme bacteria

Tufts University researchers are using AI and machine learning to more quickly identify potential narrow-spectrum antibiotics to prevent and treat Lyme disease, thanks to a generous gift from an alumnus that sped up their timeline by two to three years.

28 Apr 2026

Modeling the synergy of maternal screening and newborn HBV vaccination

Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, including chronic liver disease. Despite longstanding recommendations for prenatal screening, an estimated 12% to 16% of pregnant individuals in the US are not screened for hepatitis B. This gap leaves a portion of newborns at risk for undetected exposure.

28 Apr 2026

Scientists uncover protein switch that turns on leptospirosis virulence

During infection, pathogens must adapt quickly to the conditions to thrive inside the body. A research team at the University of Basel, Switzerland, has uncovered how a key protein switches on the machinery that enables Leptospira pathogens to survive and cause disease.

27 Apr 2026

WHO simulation tests global response to fictional bacterial pandemic

The World Health Organization (WHO) wrapped up Exercise Polaris II, a 2-day high-level simulation exercise, based around an outbreak of a fictional new bacterium spreading across the world.

27 Apr 2026

Did life-saving HIV drugs unintentionally fuel a syphilis comeback?

The introduction of HAART for HIV has coincided with a syphilis resurgence, suggesting unintended public health trade-offs from this medical breakthrough.

27 Apr 2026

Scientists map 239 human-infective RNA viruses to track future outbreak risks

Researchers updated the global catalogue of human-infective RNA viruses to 239 ICTV-recognised species, incorporating taxonomy, discovery dates, locations, genome links, host range, transmissibility, and transmission routes. The dataset shows that most known human-infective RNA viruses remain strictly zoonotic, while only a minority are endemic in humans or capable of epidemic spread.

26 Apr 2026

Researchers pioneer breakthrough therapy for life-threatening infections

A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University.

25 Apr 2026

Bacterial vesicles emerge as powerful tools against antibiotic resistance

Antibiotic resistance is making bacterial infections harder to treat, demanding new therapeutic strategies. A new review highlights bacterial extracellular vesicles (BEVs) as promising nanoscale tools that can kill pathogens, block infection, enhance vaccines, and deliver drugs.

25 Apr 2026